Table 3.
Outcome | Parameters | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|
Primary outcome | Baseline NAS | 72.7% | 71.4% | 80.0% | 57.7% |
Pioglitazone exposure index |
Outcome | Parameters | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|
Primary outcome | Baseline NAS | 72.7% | 71.4% | 80.0% | 57.7% |
Pioglitazone exposure index |